skip to main content
Back

Nutrisens announces the acquisition of Vitasyn Medical GmbH

Lyon, September 06, 2023

Nutrisens Group strengthens its position as a major independent European platform in clinical nutrition with the acquisition of Vitasyn Medical GmbH, a German specialist focusing on nephrology and oncology.

Founded in 2012 and headquartered in Berlin, Germany, Vitasyn Medical operates on the German market and offers oral and enteral products for patients suffering from renal failure and end-stage renal disease requiring dialysis treatment, as well as for patients undergoing cancer treatment. Vitasyn Medical deals directly with pharmacies, hospitals, dialysis centres or homecare units and supports private individuals as well via the e-commerce channel.

With this acquisition, Nutrisens is pursuing its European expansion, setting up a subsidiary in Germany (alongside those in France, Spain, Italy and Portugal). The Group will also benefit from Vitasyn Medical’s expertise in renal and oncology areas reinforcing the multi-niche pathologies capabilities of the Group.

Nutrisens’ acquisition of Vitasyn Medical will give its local management the strategic resources to pursue its organic development by taking advantage of Nutrisens’ broader product portfolio and production capacity.

Georges Devesa, CEO of Nutrisens, comments: “It is key for Nutrisens to take care of Vitasyn Medical’s corporate culture and team. Thanks to Vitasyn Medical, Nutrisens will reinforce its expertise in nephrological and oncological pathologies and will continue to consolidate the market on niche therapeutic areas.”

Sabina Kühne, CEO of Vitasyn Medical, adds: “I am very excited about this partnership with Nutrisens which will help Vitasyn Medical’s team to accelerate its growth in Germany. I am looking forward to work with Nutrisens team to implement the identified synergies and contribute to Vitasyn Medical’s next phase of development.”

Arno Markwitan and Michael Lindenbacher, founders of Vitasyn Medical, conclude: “In 10 years, Vitasyn Medical has achieved a remarkable journey developing a strong and successful expertise on its market. Our wish was to pass on our company with the insurance that its future would be guaranteed and the team of employees trusted. We are delighted to have chosen Nutrisens to support Vitasyn Medical’s future growth.”

About Nutrisens

European multi-specialist platform in clinical nutrition, Nutrisens has been providing every patient, whatever his pathology, the most adapted nutritional solution. For more than 10 years, Nutrisens has been the partner of health professionals covering the entire patient journey through hospitals and clinics, retirement homes, pharmacies, wholesalers and at home, so that every patient can eat with pleasure. The in-house production strongly contributes to the Group product expertise.

Few figures about Nutrisens:

  • €130 million in turnover in 2022
  • 40% of turnover abroad
  • A presence in 30 countries
  • 500 employees across Europe
  • 5 subsidiaries: France, Italy, Spain, Portugal, Germany
  • Website : www.nutrisens.com 

You might also be interested in

Norbec announces significant investment by Sagard Private Equity Canada

News

Norbec announces significant investment by Sagard Private Equity Canada

LOU-TEC and Torcan Lift Equipment Join Forces

News

LOU-TEC and Torcan Lift Equipment Join Forces

Dialogue to be Acquired by Sun Life

News

Dialogue to be Acquired by Sun Life

Connect with us

Get in touch
Back To Top